Please check your internet connection and try again.
# Isoxsuprine hydrochloride
## Overview
Isoxsuprine hydrochloride is a vasodilator. Its mechanism of action is not fully understood but is thought to involve direct relaxation of vascular smooth muscle and possibly beta-adrenergic stimulation.
## Primary Indications
* Treatment of peripheral vascular diseases such as intermittent claudication and Raynaud's phenomenon.
* *Off-label uses may exist but are not supported by robust evidence.*
## Adult Dosing
* **Typical Dose:** 10-20 mg orally every 3-4 times daily.
* **Maximum Dose:** Not clearly established, but doses exceeding 20 mg 4 times daily are generally not recommended.
## Pediatric Dosing
* There is no established pediatric dosing for isoxsuprine hydrochloride. Its use in pediatric populations is generally not recommended due to lack of safety and efficacy data.
## Dose Adjustments
* No specific dose adjustments are routinely recommended for renal or hepatic impairment. However, caution should be exercised.
## Contraindications
* Hypersensitivity to isoxsuprine hydrochloride.
* Use immediately following coronary occlusion.
* Tachyarrhythmias.
* In patients where increased peripheral circulation is undesirable.
## Adverse Effects
* **Common:** Nausea, vomiting, gastrointestinal distress, dizziness, weakness, flushing, nervousness, drowsiness.
* **Less Common:** Hypotension, rash, abdominal pain, blurred vision, headache.
* **Serious:** Palpitations, arrhythmias, chest pain (especially in patients with heart disease).
## Key Drug Interactions
* **Antihypertensives:** May potentiate hypotensive effects.
* **Drugs affecting gastric pH (e.g., antacids):** May potentially alter absorption, though clinical significance is unclear.
## Monitoring
* Blood pressure and heart rate.
* Symptoms of peripheral vascular disease.
* Signs of adverse effects, particularly cardiovascular events.
## Clinical Pearls
* Efficacy in peripheral vascular disease is controversial and not well-supported by high-quality evidence.
* Patients with underlying cardiovascular disease should be closely monitored for potential adverse effects.
* The drug's effectiveness is often subjective and patient-reported.
***
*This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant literature for complete details before making clinical decisions. Dosing and indications may vary based on local guidelines and individual patient factors.*
